136 related articles for article (PubMed ID: 37745978)
1. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma.
Yang J; Zhou F; Yang X; Ma P; Ma X
Open Med (Wars); 2023; 18(1):20230773. PubMed ID: 37745978
[TBL] [Abstract][Full Text] [Related]
2. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
Liu Y; Jian J; Zhang Y; Wang L; Liu X; Chen Z
Front Oncol; 2023; 13():1170893. PubMed ID: 37124542
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
Front Oncol; 2022; 12():724261. PubMed ID: 35237505
[TBL] [Abstract][Full Text] [Related]
4. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
5. Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro.
Li Y; Xu K; Zhang Y; Mao H; Qiu Q; Yan Z; Liu X; Du Y; Chen Z
BMC Cancer; 2023 Oct; 23(1):1021. PubMed ID: 37872487
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
Zhang F; Liang J; Feng D; Liu S; Wu J; Tang Y; Liu Z; Lu Y; Wang X; Wei X
Front Cell Dev Biol; 2022; 10():814735. PubMed ID: 35281080
[No Abstract] [Full Text] [Related]
8. A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma.
Zhou Z; Zhou Y; Liu W; Dai J
Front Genet; 2023; 14():1148430. PubMed ID: 37065485
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
PeerJ; 2023; 11():e15284. PubMed ID: 37123010
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration.
Huang C; Li Y; Ling Q; Wei C; Fang B; Mao X; Yang R; Zhang L; Huang S; Cheng J; Liao N; Wang F; Mo L; Mo Z; Li L
FEBS Open Bio; 2023 Apr; 13(4):736-750. PubMed ID: 36814419
[TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
Front Oncol; 2021; 11():726486. PubMed ID: 34966666
[TBL] [Abstract][Full Text] [Related]
13. Identification and Development of Inflammatory Response-Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer.
Zheng H; Luo W; Li Y; Peng G; Zhou D; Tang D; Cheng J; Wu S
Front Cell Dev Biol; 2022; 10():837849. PubMed ID: 35309900
[No Abstract] [Full Text] [Related]
14. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma.
Wan Z; Wang Y; Li C; Zheng D
Open Life Sci; 2023; 18(1):20220682. PubMed ID: 37588995
[TBL] [Abstract][Full Text] [Related]
15. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
17. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
Liu D; Zhou B; Liu R
PeerJ; 2020; 8():e9422. PubMed ID: 32742772
[TBL] [Abstract][Full Text] [Related]
18. Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer.
Zhou G; Li Y; Ren X; Qin G; Zhang Z; Zhao H; Gao L; Jiang X
Cancer Cell Int; 2023 Nov; 23(1):300. PubMed ID: 38017469
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
20. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]